Edwards Lifesciences EW Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Edwards Lifesciences in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Edwards Lifesciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Edwards Lifesciences's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Edwards Lifesciences's financing cash flow?
- Edwards Lifesciences (EW) reported financing cash flow of -$451.2M in Q1 2026.
- How has Edwards Lifesciences's financing cash flow changed year-over-year?
- Edwards Lifesciences's financing cash flow decreased by 74.9% year-over-year, from -$258M to -$451.2M.
- What is the long-term trend for Edwards Lifesciences's financing cash flow?
- Over 3 years (2022 to 2025), Edwards Lifesciences's financing cash flow has grown at a -14.0% compound annual growth rate (CAGR), from -$1.58B to -$1.01B.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.